Skip to main content
logo
Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.500
-0.200 (-11.76%)
Mar 20, 2026, 11:15 AM EDT - Market open

Milestone Pharmaceuticals Revenue

In the year 2025, Milestone Pharmaceuticals had annual revenue of $1.55M. Milestone Pharmaceuticals had revenue of $1.55M in the quarter ending December 31, 2025.

Revenue (ttm)
$1.55M
Revenue Growth
n/a
P/S Ratio
99.87
Revenue / Employee
$46,848
Employees
33
Market Cap
152.37M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.55M--
Dec 31, 2024---
Dec 31, 20231.00M-4.00M-80.00%
Dec 31, 20225.00M-10.00M-66.67%
Dec 31, 202115.00M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Protalix BioTherapeutics52.74M
Precision BioSciences34.26M
ProQR Therapeutics19.19M
Evaxion7.53M
Whitehawk Therapeutics7.15M
Cartesian Therapeutics2.80M
Molecular Partners AG856.30K
Adagene103.20K
Revenue Rankings

MIST News

More News